ResearchMoz

Dyslexia Global Clinical Trials Review, H1, 2013

GlobalData
Published Date » 2013-04-12
No. Of Pages » 59
 Dyslexia Global Clinical Trials Review, H1, 2013  Summary   GlobalData's clinical trial report, Dyslexia Global Clinical Trials Review, H1, 2013" provides data on the Dyslexia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Dyslexia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. 
   
 The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Dyslexia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house...
Table of Content

Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Dyslexia 5
Symptoms of dyslexia are: 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by BRIC Nations 13
Clinical Trials by G7 Nations 14
Clinical Trials in G7 Nations by Trial Status 15
Clinical Trials by E7 Nations 16
Clinical Trials in E7 Nations by Trial Status 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Unaccomplished Trials of Dyslexia 21
Subjects Recruited Over a Period of Time 22
Prominent Sponsors 23
Prominent Drug Comparison 25
Clinical Trial Profiles 26
Clinical Trial Overview of Top Companies 26
Eli Lilly and Company 26
Clinical Trial Overview of Eli Lilly and Company 26
Clinical Trial Overview of Top Universities / Institutes / Hospitals 27
University Hospital, Tours 27
Clinical Trial Overview of University Hospital, Tours 27
Macquarie University 28
Clinical Trial Overview of Macquarie University 28
University of Tasmania 29
Clinical Trial Overview of University of Tasmania 29
University of Munster 30
Clinical Trial Overview of University of Munster 30
McGill University 31
Clinical Trial Overview of McGill University 31
University of Oxford 32
Clinical Trial Overview of University of Oxford 32
Vanderbilt University 33
Clinical Trial Overview of Vanderbilt University 33
Rabin Medical Center 34
Clinical Trial Overview of Rabin Medical Center 34
Five Key Clinical Profiles 35

Appendix 57
Abbreviations 57
Definitions 57
Research Methodology 58
Secondary Research 58
About GlobalData 59
Contact Us 59
Disclaimer 59
Source 59

List of Tables


Dyslexia Therapeutics Market, Global, Clinical Trials by Zone, 2013* 6
Dyslexia Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 7
Dyslexia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 8
Dyslexia Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2013* 9
Dyslexia Therapeutics Clinical Trials, Europe, Top Countries, 2013* 10
Dyslexia Therapeutics Clinical Trials, North America, Top Countries, 2013* 11
Dyslexia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013* 12
Dyslexia Therapeutics Clinical Trials, BRIC Countries, 2013* 13
Dyslexia Therapeutics Clinical Trials, G7 Countries, 2013* 14
Dyslexia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 15
Dyslexia Therapeutics Clinical Trials, E7 Countries, 2013* 16
Dyslexia Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 17
Dyslexia Therapeutics Market, Global, Clinical Trials by Phase, 2013* 18
Dyslexia Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 19
Dyslexia Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 20
Dyslexia Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 21
Dyslexia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 22
Dyslexia Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 24
Dyslexia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 25
Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2013* 26
Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Tours, 2013* 27
Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Macquarie University, 2013* 28
Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Tasmania, 2013* 29
Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Munster, 2013* 30
Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by McGill University, 2013* 31
Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2013* 32
Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2013* 33
Dyslexia Therapeutics Clinical Trials Market, Global, Clinical Trials by Rabin Medical Center, 2013* 34

List of Figures


Dyslexia Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 6
Dyslexia Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 7
Dyslexia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 8
Dyslexia Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2013* 9
Dyslexia Therapeutics Clinical Trials, Europe, Top Countries (%), 2013* 10
Dyslexia Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 11
Dyslexia Therapeutics Clinical Trials, G7 Countries (%), 2013* 14
Dyslexia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 15
Dyslexia Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 18
Dyslexia Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 19
Dyslexia Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 20
Dyslexia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 22
Dyslexia Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 23
Dyslexia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 25
GlobalData Methodology 58

Upcoming Reports:

E-Clinical Trial Solutions Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
E-clinical trial solutions are a combination of technology, products and services that work together to automate and manage clinical trials. This term is used to refer to electronic systems that are used for conducting or automating the management of clinical trials and minimizing human errors.Conducting clinical trials for a novel drug requires efficient management of large amount of essential data with real-time analysis.Such management solutions improve efficiency, enhance the speed of clinical trials process, reduce clinical trial costs, and enable better data management...
Blood Pressure Monitoring & Measurement Instruments Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts 2012 - 2018
By - Transparency Market Research
The global market for blood pressure monitoring and measurement equipment is forecasted to reach $2.2 billion by the year 2015 driven by growing elderly population suffering from blood pressure problems, increasing consumer awareness about regular health check-ups, technological developments in monitoring systems, and increasing stress on healthcare industry in developing nations. Attractive features of blood pressure measuring instruments and convenience in using these devices is also fueling the market growth. Ambulatory monitoring is emerging as an important tool for diagnosing...
Hygiene Products Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts, 2012 - 2018
By - Transparency Market Research
Some of the major factors driving the growth of hygiene products market are rising concerns about personal hygiene and product innovations. Although, feminine hygiene products share the maximum market size, men’s hygiene products are also growing in demand. This is opening new opportunities for the hygiene product manufacturers to develop innovative personal care products. This market is witnessing phenomenal growth since the past few years as a result of improvement in standards of living and the growth in public attention towards women’s health. Full-fledged advertising...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Bristol-Myers Squibb Posts USD 3.9 billion Revenues in 2014 Second Quarter
Jul 30, 2014  
Leading bio-pharmaceutical company Bristol-Myers Squibb has registered revenues of USD 3.9 billion in the 2014 second quarter. This marks a 4% decrease from the same period in 2013. The global revenues of the company (excluding the divested Diabetes Alliance), saw a 7% increase. In this quarter, the company’s results were underlined by steady global sales of nearly each of its...
Novartiss Simbrinza gets approval from the EU
Jul 30, 2014  
Glaucoma patients in Europe can easily obtain Novartis’ Simbrinza eye drops which are a combination of brimonidine tartrate and brinzolamide and it is without a beta-blocker. This eye drop has got the approval of the European Commission. Unlike the inefficient treatment provided by monotherapy, this eye drop aims at treating intraocular pressure or IOP in adults with ocular hypertension...
Second Treaty Between Zealand And Boehringer Ingelheim
Jul 30, 2014  
Denmark based Pharma group Zealand Pharma and Germany’s Boehringer Ingelheim have signed an accord to formulate new medicines for advanced and effective treatment of cardio-metabolic maladies. The collaboration between these two Pharma groups involves a new therapeutic peptide project from the list of preclinical programs of Zealand Pharma.  Both these companies are aiming...
Export market in New Zealand driven by innovative and high-value food products
Jul 29, 2014  
Demand for beverages and high value foods in Asia are driving the food and beverage industry in New Zealand. Also there is high demand for dairy products, seafood, meat and processed foods in the Asian economies which fuel the give an export boost to the economy of New Zealand.  Asia has a rapidly growing market for food which in turn is highly beneficial for New Zealand’s export...
Sony plans revival of PlayStation with network services
Jul 29, 2014  
After a nearly USD 10 billion loss over the last six years, Sony Corp has plans of reviving its consumer electronics hero – the PlayStation. Sony will be repositioning the video game console as a center of streamed network services such as social media, music and movies apart from games. The matter is still in its infancy stage of discussion and the plan is to generate revenue from the...